Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in Penn's Abramson Cancer Center, was named the winner of the 92nd annual Philadelphia Award. Dr. June is being honored for his groundbreaking advancements in gene therapy aimed at treating HIV and cancer, specifically chronic lymphocytic leukemia and acute lymphoblastic leukemia. Created in 1921, the Philadelphia Award honors those who performed or brought to culmination an act or contributed a service calculated to advance the best and largest interest of the community. Implications of June's research using genetic modifications to treat blood cancers and HIV "are historic and may forever change the way physicians treat certain types of cancers around the world," said Philadelphia Award Board of Trustees Chair Natalye Paquin.
View more videos at: http://nbcphiladelphia.com.